Source: Endpoints News

Pfizer: GSK and Pfizer resolve RSV vaccine patent fight

GSK and Pfizer have settled a lawsuit alleging Pfizer's RSV shot Abrysvo infringed GSK's patents. A Pfizer spokesperson told Endpoints News that as part of the settlement,"Pfizer has been granted a worldwide license to certain ...

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
Albert Bourla's photo - Chairman & CEO of Pfizer

Chairman & CEO

Albert Bourla

CEO Approval Rating

69/100

Read more